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Neural cell adhesion molecule close homolog of L1 (CHL1) is
a regulator of topographic targeting of thalamic axons to the
somatosensory cortex (S1) but little is known about its cooperation
with other L1 class molecules. To investigate this, CHL12/2/L12/y
double mutant mice were generated and analyzed for thalamocort-
ical axon topography. Double mutants exhibited a striking posterior
shift of axons from motor thalamic nuclei to the visual cortex (V1),
which was not observed in single mutants. In wild-type (WT)
embryos, L1 and CHL1 were coexpressed in the dorsal thalamus
(DT) and on fibers along the thalamocortical projection in the
ventral telencephalon and cortex. L1 and CHL1 colocalized on
growth cones and neurites of cortical and thalamic neurons in
culture. Growth cone collapse assays with WT and mutant neurons
demonstrated a requirement for L1 and CHL1 in repellent responses
to EphrinA5, a guidance factor for thalamic axons. L1 coimmuno-
precipitated with the principal EphrinA5 receptors expressed in the
DT (EphA3, EphA4, and EphA7), whereas CHL1 associated
selectively with EphA7. These results implicate a novel mechanism
in which L1 and CHL1 interact with individual EphA receptors and
cooperate to guide subpopulations of thalamic axons to distinct
neocortical areas essential for thalamocortical connectivity.
Keywords: axon guidance, cell adhesion molecule, Ephrin, L1,
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Introduction
L1 family neural cell adhesion molecules (L1-CAMs) are
immunoglobulin (Ig) class transmembrane receptors with
critical functions in neurodevelopment. Members of this
family—L1, close homolog of L1 (CHL1), NrCAM, and neuro-
fascin—are widely expressed in the developing nervous system
and regulate axon guidance and synaptic plasticity (Maness and
Schachner 2007). L1 mutations at human chromosomal locus
Xq28 result in a pleiotropic syndrome of mental retardation
(Kenwrick et al. 2000), and the human homolog of CHL1 at
3p26.1 (CALL) is implicated in the 3p-syndrome of low IQ and
developmental delay (Frints et al. 2003). L1 null mutant mice
display errors of axon guidance in the corticospinal tract (CST)
(Dahme et al. 1997; Cohen et al. 1998), corpus callosum
(Demyanenko et al. 1999), and retinocollicular projection
(Demyanenko and Maness 2003; Buhusi et al. 2008), and they
are learning impaired (Fransen et al. 1998). CHL1 null mutant
mice show aberrant thalamocortical projections (Wright et al.
2007), abnormal positioning of cortical neurons (Demyanenko
et al. 2004), deficits in cognitive processing of spatial
information (Montag-Sallaz et al. 2002), attention, sensory
gating (Pratte et al. 2003; Irintchev et al. 2004), and working
memory (Kolata et al. 2008). L1 and CHL1 phenotypes differ,
but they have not been examined for an ability to cooperate in
guiding axons to synaptic targets. To this end, we generated
L1/CHL1 double mutant mice and analyzed the combined
effect of loss of both L1-CAMs on topographic mapping of
thalamocortical axons.
The topographic projection of axons from discrete nuclei in
the dorsal thalamus (DT) to specific neocortical areas is vital for
proper cortical connectivity. Topographic mapping of the
thalamocortical projection is organized along 2 axes. During
embryogenesis, thalamic afferents originating in rostral tha-
lamic nuclei, the ventroanterior (VA) and ventrolateral (VL)
nuclei, project to rostromedial neocortical areas; while axons
from caudal thalamic nuclei, such as the dorsal lateral
geniculate nucleus (LGN) project to caudolateral areas (Price
et al. 2006). CHL1 has been shown to regulate topographic
mapping of thalamic axon contingents from the ventrobasal
(VB) complex located in the middle of the DT to the primary
somatosensory cortex (S1), specifically mediating thalamic
axon guidance at the ventral telencephalon (VTe) (Wright et al.
2007). The VTe is a key intermediate sorting target that directs
embryonic thalamic axons toward different rostrocaudal areas
of the neocortex (Dufour et al. 2003). Deletion of CHL1 causes
a caudal shift within the VTe of axons from the middle DT,
resulting in final mistargeting of VB axon contingents to V1 in
the caudal region of the neocortex (Wright et al. 2007). CHL1
functions on DT axon subpopulations by mediating repulsive
axon guidance to the high-caudal gradient of Semaphorin3A
(Sema3A) in the VTe, achieved by serving as a coreceptor for
Sema3A by binding Neuropilin-1 (Wright et al. 2007). Because
L1 shares significant homology with CHL1 and also mediates
Sema3A repulsive responses by binding Neuropilin-1 (Bechara
et al. 2008), L1 might coordinate functionally with CHL1 to
regulate thalamocortical axon guidance. However, L1-CAMs
may have broader roles in repellent guidance by functioning as
coreceptors for other axon guidance cues acting in the VTe. In
particular, L1-CAMs could conceivably mediate axon repulsion
to a high-caudal gradient of EphrinA5 in the VTe, which is
known to direct rostral DT axons with elevated expression of
EphA receptors to the primary motor cortex (M1) (Dufour
et al. 2003). Little is known about interactions of L1-CAMs with
EphA receptors in neurons. L1 is involved in reverse signaling
through EphrinB in retinal ganglion cells in culture (Suh et al.
2004) and binds EphA4 in platelets (Prevost et al. 2002), but
a role in axon guidance in vivo has not been investigated.
To investigate functions for CHL1 and L1 in topographic
mapping of thalamocortical axons, we generated a novel
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strain of CHL1
–/–/L1
–/y double mutant mice and analyzed
their thalamocortical topographic map by axon tracing.
CHL1
–/–/L1
–/y double mutants exhibited a striking caudal
shift of motor DT axons to V1, similar to the phenotype of
EphA/EphrinA mutant mice, whereas single mutants did not
exhibit this misprojection. Furthermore, L1 and CHL1 were
coexpressed on thalamic axons along the developing thala-
mocortical trajectory, associated with EphA receptors, and
mediated EphrinA5-induced growth cone collapse. These
results suggest a novel cooperative function for L1 and CHL1
in topographic mapping of thalamic axon populations to the




The L1 gene is located on the X chromosome, and its deletion results in
poor breeding capability of males and thus female mice homozygous
null for the CHL1 gene and heterozygous for L1 (CHL1
–/–/L1
+/–; C57BL/
6/Sv129, ~9:1) were crossed with CHL1–/–/L1+/y males (C57BL/6) to
produce CHL1
–/–/L1
–/y double mutants. To visualize the boundary




+/y mice were intercrossed with Thy1-yellow fluorescent protein
(YFP) line H reporter mice (C57BL/6 [Feng et al. 2000]), in which layer





+/y males were then crossed with
CHL1
–/–/L1





mutants. Embryonic day 0.5 (E0.5) was defined as the plug date and
postnatal day 0 (P0) as the day of birth. Animal care and treatment were
in accordance with guidelines provided by the University of North
Carolina Institutional Animal Care and Use Committee.
Immunostaining, Analysis of Cortical and Thalamic Areas, and
Preparation of Neuronal Cultures
Immunofluorescence staining was conducted using 10-lm frozen
sections of mouse brain using antibodies directed against CHL1 (goat
polyclonal anti-CHL1, R&D Systems; 1:200) and L1 (rat polyclonal anti-
L1, Abcam; 1:50) as described (Demyanenko et al. 1999), with FITC- or
rhodamine-conjugated secondary antibodies. The specificity of these
antibodies for CHL1 and L1, respectively, in mouse forebrain from E13
through adulthood has been demonstrated (Demyanenko et al. 1999;
Nikonenko et al. 2006; Wright et al. 2007; Guseva et al. 2009). Nissl
staining was carried out on 40-lm brain sections as described
(Demyanenko et al. 1999).
For preparation of neuronal cultures, cortical or thalamic neurons
(E14.5) were dissociated by trituration using a fire-polished Pasteur
pipette. Cells were plated on poly-D-lysine, and fibronectin-coated
chamber slides in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum. One day after plating,
the media was changed to Neurobasal media containing B27
supplement and glutamate (25 lM). After 72 h, cortical cells were
fixed in 4% paraformaldehyde (PFA) and permeabilized with 0.05%
Triton in phosphate-buffered saline (PBS). Thalamic cells were fixed in
methanol/acetone (1:1). After blocking in 10% donkey serum/PBS, cells
were double stained with antibodies against L1 (rat polyclonal anti-L1,
Abcam; 1:100) and CHL1 (1:100) followed by incubation with TRITC-
conjugated donkey anti-rat IgG (1:150) and FITC-conjugated donkey
anti-goat IgG (1:150). Staining was analyzed using an Olympus
FluoView500 laser scanning confocal microscope.
In Situ Hybridization
cDNA including nucleotides 2866--3523 of L1 cDNA (NM_008478) was
subcloned into NotI and KpnI sites in psBluescript SK and used as
a template to generate L1 probes. The sense probe was generated by
linearizing the plasmid with NotI and transcribing with T3 polymerase.
The antisense probe was generated by linearizing the plasmid with
KpnI and transcribing with T7 polymerase. Brains from wild-type (WT)
embryos (E14.5; C57BL/6) were immersion fixed in 4% PFA overnight
and cryoprotected in sucrose before sectioning in the horizontal plane.
Alternatively, cryostat sections from unfixed brains were mounted onto
slides and fixed with 4% PFA before being subjected to in situ
hybridization analysis. In situ hybridization was performed as described
using digoxigenin-labeled probes as described (Bartsch et al. 1994).
Retrograde Tracing of Thalamocortical Axons
Retrograde axon tracings were performed as described (Wright et al.
2007) by focal injection of solutions of DiI (1,1#, di-octadecyl-3,3,3#,3#-
tetramethylindocarbocyanine perchlorate) or DiA (4,4-dihexadecyl
aminostyryl N-methyl-pyridinium iodide) (Invitrogen, Inc.; 5% in ethanol)
into the primary motor (M1), somatosensory (S1), or visual (V1) cortical
areas of living mice at postnatal day 5 (P5), anesthetized by hypothermia.
Injections were made with capillary micropipettes connected to
a Picospritzer II. Mice were euthanized 2 days later, and brains were
fixed by transcardial perfusion. Forebrains were vibratome sectioned in
the coronal plane (100 lm), and injection sites were monitored
microscopically. Only injections restricted to the neocortex without
entering the white matter were analyzed. Sections were analyzed for
labeling of cell bodies of individual thalamic nuclei by epifluorescence
and confocal microscopy. 4#,6-diamidino-2-phenylindole nuclear stain-
ing was used to identify the position of the thalamic nuclei by
comparison with atlas coordinates (Paxinos et al. 2007). Further details
of the protocol and analysis are provided in Wright et al. (2007).
Growth Cone Collapse Assay
Growth cone collapse assays were performed as previously described
(Wright et al. 2007). Cortical tissue was obtained from WT and L1
–/y
embryonic brains (E14.5) by microdissection in ice-cold Hank’s
balanced salt solution (HBSS). Dissociated cortical neurons were
produced as described above and subjected to double staining for L1
and CHL1. After culturing for 72 h, cells were treated with either
EphrinA5 fused to Fc (EphrinA5-Fc) or nonimmune Ig (control) (30 nM
each) for 30 min. Cells were fixed with 4% PFA and actin labeled with
rhodamine-conjugated phalloidin (Invitrogen; 1:40). Axons were
scored for growth cone collapse by morphological criteria using
fluorescence microscopy. Growth cones were scored as collapsed if
they had a bullet-shaped morphology, whereas they were scored as
uncollapsed if they were well spread and displayed numerous filopodia
and lamellipodia. Values represent means ± standard error of the mean.
Student’s t-test was utilized to compare different treatment groups as
indicated. P < 0.05 was considered significant.
For preparation of explants, WT and CHL1
–/– embryonic brains
(E14.5) were vibratome sectioned (300 lm), and thalamic regions were
obtained by microdissection in ice-cold HBSS. Explants were plated on
fibronectin-coated MatTek dishes using a plasma clot (20 lL of bovine
thrombin with 20 lL of chicken plasma, Sigma) to ensure adherence of
the explants. The explants were cultured for 48 h and treated with
either Fc protein fused to alkaline phosphatase (AP) (Fc-AP; 30 nM) or
EphrinA5 fused to AP (EphrinA5-AP, 30 nM; [Flanagan and Cheng 2000])
for 30 min. Fc-AP and EphrinA5-AP were prepared by transfecting HEK-
293T cells using Lipofectamine 2000 (Needham et al. 2001) and
purified as described (Flanagan and Cheng 2000). After 2 days, media
was collected and the concentration of the Fc proteins was determined
(Flanagan and Cheng 2000). Explants were fixed and stained, growth
cone morphology was analyzed using confocal microscopy, and data
analysis was performed as described above.
Coimmunoprecipitation
HEK293T cells were maintained in DMEM containing 10% bovine calf
serum and transiently transfected with pcDNA3 constructs encoding
mouse CHL1, human L1, rat EphA7 (from Dr Masaaki Torii) and mouse
EphA3, chicken EphA4, and chicken EphB2 (from Dr Elena Pasquale)
using Lipofectamine 2000 as described (Needham et al. 2001). Two
days after transfection, HEK293T cells were washed with HBSS and
lysed in either RIPA buffer (20 mM Tris--HCl [pH 7.4], 150 mM NaCl,
5 mM ethylenediaminetetraacetic acid [EDTA]-Na, 1 mM
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ethyleneglycol-bis(2-aminoethylether)-N,N,N’,N’-tetra acetic acid
[EGTA]-Na, 1% NP40, 1% sodium deoxycholate, 0.1% sodium dodecyl
sulfate [SDS], 10 mM NaF, 10 lg/mL leupeptin, 1% aprotinin, and 0.2
mM Na3VO4) or Brij-97 buffer (1% Brij-97, 10 mM Tris--HCl [pH 7.4],
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 500 lg/mL Pefabloc, 10 mM
NaF, 10 lg/mL leupeptin, 1% aprotinin, and 0.2 mM Na3VO4). Protein
concentrations in the lysates were determined using the BCA protein
assay. For immunoprecipitation, 0.5-mL lysate (500 lg) was precleared
with nonimmune IgG and A/G agarose beads for 30 min at 4 C.
Supernatants were incubated for 1 h with either normal IgG (control)
or 1--2 lg each of specific antibodies, and immune complexes collected
after 30-min incubation with protein A/G agarose. The immunopreci-
pitates were washed with lysis buffer and processed for immunoblot-
ting by separation of samples (25 lg) on 7.5% SDS--polyacrylamide gels
and transferred to nitrocellulose membranes. Nonspecific binding was
blocked by incubating 1 h in Tris-buffered saline containing 0.05%
Tween 20 (TBST) and 5% nonfat dry milk. Membranes were incubated
overnight in primary antibody, washed with TBST, and then incubated
for 1 h with horse radish peroxidase-conjugated secondary antibody.
After 3 washes in TBST, the blots were developed by enhanced
chemiluminescence (Amersham Biosciences) and exposed to autora-
diographic films.
Results
Generation and Characterization of CHL1–/–/L1–/y Double
Mutant Mice
To investigate cooperative functional roles for CHL1 and L1 in
thalamocortical mapping, CHL1
–/–/L1
–/y double mutant mice
were generated. Among offspring, double mutant males were
produced at a reduced Mendelian frequency of 8.7%, instead of
the expected 25%, but were viable and survived to adulthood.
Double mutants (8 weeks of age) were smaller than normal
(Fig. 1A) with body weights 55--60% of CHL1
–/– single mutants
or WT mice. L1
–/y single mutants have body weights that are
60--80% of WT (Dahme et al. 1997), thus the smaller size of the
double mutants most likely reflected the loss of L1. Because L1
and CHL1 are also expressed in some hematopoietic cells and
elsewhere outside the brain (Maness and Schachner 2007),
immune dysfunction or some other deficiency may contribute
to the reduced body size of mutant mice. The cerebral cortex
of CHL1
–/–/L1
–/y double mutants (postnatal day 21; P21) had
a normal thickness and laminar neuronal distribution in all
neocortical areas, as shown in the primary somatosensory
cortex (S1) (Fig. 1B). The double mutant brain also displayed
grossly normal neuroanatomy in the cerebral cortex, hippo-
campus, corpus callosum, cerebellum, ventricles, thalamus,
optic nerve, and olfactory bulb (not shown). Nissl staining
showed normal positioning of M1 in double mutants (P7) with
typical barrels (Fig. 1C--Dd, circled), as well as normally
positioned thalamic nuclei VL, VB, mediodorsal (Fig. 1H,I),
and dLGN (Fig. 1J,K). To assess potential defects at the V1/V2
boundary that might perturb axon targeting, CHL1
–/–/L1
–/y
mice were intercrossed with Thy1-YFP line H reporter mice
(Feng et al. 2000), in which layer V pyramidal cells express YFP
in V2 but not V1, thus marking the boundary between these




mutants (P21) displayed normal positioning of V1 and V2
compared with WT/YFP
+
mice (Fig. 1E--G). L1 and CHL1 are
known to colocalize in the neonatal CST at medullary pyramids
and at the pyramidal decussation, and loss of L1 in L1-minus
mice results in a size reduction of the CST and impaired
decussation (Dahme et al. 1997; Cohen et al. 1998; Runker
et al. 2003). Adult CHL1
–/–/L1
–/y double mutant mice, but not
CHL1
–/– single mutants, exhibited a reduced cross-sectional
area of the CST at caudal levels of the medulla but the size
reduction was not significantly greater than in L1
–/y mice (not
shown).
Colocalization of L1 and CHL1 in the Thalamocortical
Pathway
To determine if L1 and CHL1 were coexpressed in mouse
embryos during thalamocortical pathfinding, double immuno-
fluorescence staining was carried out in the DT in mouse
embryos at E14.5, when thalamic axons extend from
the thalamic eminence (TE) through the VTe ‘‘en route’’ to
the cortex (Fig. 1L--N). L1 and CHL1 were localized on fibers in
the DT and were prominent in axons extending through the
TE and VTe (Fig. 1L--N). In the VTe at higher magnification,
many fibers were seen that expressed both L1 and CHL1, but
some expressed only L1 and fewer expressed only CHL1
(Fig. 1O--T). In the DT (Fig. 1U--W), L1 and CHL1 colocalized
along much of the rostrocaudal axis; however, CHL1 was
preferentially enriched in medially and L1 somewhat enriched
laterally. The L1 and CHL1 antibodies have been shown to be
specific for each protein and do not label L1
–/y or CHL1
–/– brain,
respectively (Nikonenko et al. 2006; Guseva et al. 2009). L1 and
CHL1 were also expressed in the E14.5 neocortex (Fig. 1L--M
and X--Z). These L1-CAMs colocalized in many but not all fibers
of the cortical intermediate zone (IZ) and in the marginal zone,
with less expression in the cortical plate and little expression in
the ventricular zone (Fig. 1Z). These experiments confirm and
extend results on L1 expression in the E14--18 mouse cortical
IZ (Kudo et al. 2005) and on thalamic axons within the E16 rat
cortex and internal capsule (Fukuda et al. 1997) by demon-
strating colocalization of L1 with CHL1 on specific fibers within
the VTe and neocortex. In situ hybridization in the E14.5 DT
revealed L1 transcripts throughout the rostrocaudal extent of
the DT (Fig. 1Aa). L1 transcripts generally occupied a similar
DT location as CHL1 transcripts, as shown previously (Wright
et al. 2007), although L1 transcripts were more abundant than
CHL1 transcripts in the far rostral DT, while CHL1 transcripts
were enriched in the central region of the DT (Wright et al.
2007). The rostral DT contains the developing VA and VL motor
nuclei, while the central DT contains the developing VB
thalamic nuclei, and caudal DT contains the dorsal LGN.
CHL1 and L1 Cooperate to Regulate Thalamocortical
Axon Targeting
To investigate whether L1 cooperates with CHL1 in area-
specific thalamocortical axon mapping, retrograde axon tracing
of WT, homozygous CHL1
–/–/L1
–/y double knockout, and L1
–/y
mutant mice was performed in live anesthetized mice at
postnatal day 5 (P5), when final thalamocortical topography is
established (Agmon et al. 1995). Retrograde axon tracing of
thalamic axons in postnatal mice was performed by injecting
DiI or DiA into different neocortical areas (primary motor [M1],
somatosensory [S1], or visual cortex [V1]) then analyzing
labeled neuronal cell bodies in thalamic nuclei after 36 h
(Fig. 2). The accuracy of all injections was monitored by
epifluorescence microscopy. Projections of afferents from DT
nuclei to cortical areas in different mouse genotypes are
depicted in summary schemes illustrating primarily the
rostrocaudal axis (Fig. 2A--D), facilitating comparison with
horizontal brain sections showing retrograde labeling of DT
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Figure 1. Analysis of CHL1//L1/y double mutant mice and expression of CHL1 and L1 in the thalamocortical pathway. (A) CHL1//L1/y double mutant mice are reduced in
size compared with CHL1/ mutant mice. (B) Nissl staining of primary somatosensory cortex in WT, L1/y, CHL1/, and CHL1//L1/y mice (P21) in coronal sections. (C and
D) Nissl staining of S1 cortex in WT (C) and CHL1//L1/y mice (D) (P7) showing normal barrels (circled in WT Cc and mutant Dd). (E--G) Normal boundary between V1 and
V2 visualized by YFP-expressing layer V pyramidal neurons in WT (E), CHL1/ (F), and CHL1//L1/y mice crossed to Thy1-YFP (line H) reporter mice at P21. (H--K) Normal size
and location of DT nuclei visualized by Nissl staining of WT (H) and CHL1//L1/y double mutant mice (I) at P7. dLGN, dorsal LGN nuclei. (L--N) Immunofluorescence staining for
L1 and CHL1 in the thalamocortical pathway of WT embryos (E14.5) in midcoronal sections. C1, L1/y brain stained with L1 antibody. C2, CHL1/ brain stained with CHL1
antibody. (O--P) Immunofluorescence staining for L1 and CHL1 in the VTe of WT embryos (E14.5) in coronal sections. (R--T) Higher magnification images of L--N. (U--W)
Immunofluorescence staining for L1 and CHL1 in the DT of WT embryos (E14.5) in horizontal sections. R, rostral; C, caudal; m, medial, l, lateral. (X--Z) Immunofluorescence
staining for L1 and CHL1 in the neocortex of WT embryos (E14.5). MZ, marginal zone; CP, cortical plate; VZ, ventricular zone. (Aa) In situ hybridization for L1 mRNA in serial
horizontal sections of WT embryos (E14.5). L1 transcripts were present throughout the DT (dashed lines). (Bb) No expression was observed with the sense probe (control).
Magnification bar 5 100 lm in B; 200 lm in C and D; 500 lm in Aa, E--N, U--W; 300 lm in O--Q; 50 lm in X--Z.
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nuclei. In vivo, rostral DT nuclei such as VA/VL actually project
rostromedially to M1, and caudal DT nuclei such as the dorsal
LGN, project caudolaterally to V1 (Price et al. 2006). In all WT
mice (13 of 13 injections), retrograde labeling of neuronal cell
bodies in the DT following single injections of DiI into M1
labeled only VA/VL nuclei and not VB nuclei ventroposterior
medial (VPM) and ventroposterior lateral (VPL) (Fig. 2A1) or
dorsal LGN (not shown) as described before (Molnar et al.
2003; Vanderhaeghen and Polleux 2004; Wright et al. 2007).
Dual injection of DiA into S1 and DiI into V1 of WT mice
resulted in specific labeling of VB and the dorsal LGN,
respectively, also as expected (Fig. 2A2).
Retrograde labeling of thalamocortical axons in L1
–/y
mutants following single DiA injections into M1 labeled only
motor thalamic nuclei, VA/VL in 3 out of 3 mice, as shown for
VL (Fig. 2B1) with no labeling of VB (VPL, VPM) or dorsal
LGN. Injections of DiI into S1 of L1
–/y mice labeled only VB
nuclei in 7 out of 7 injections (Fig. 2B2) with no labeling of
other DT nuclei. DiI injections into V1 of L1
–/y mice showed
labeling of only the dorsal LGN with no labeling of motor
or somatosensory thalamic nuclei (6 out of 6 injections)
(Fig. 2B3; inset at higher magnification). Comparison with WT
mice above (n = 13 injections) indicated that there were no
significant differences (Chi-square, 1 degree of freedom =
undefined). Thus, motor, somatosensory, and dorsal LGN
thalamic axons projected normally in L1
–/y mice. These results
were in accord with a thalamocortical axon tracing study
(Wiencken-Barger et al. 2004) that differed in using fixed
brains of L1
–/y mice (n = 3) at an older age P14, which showed
normal retrograde labeling of VB and dorsal LGN after
injection of lipophilic dyes into S1 and V1, respectively.
Thalamocortical axons in CHL1
–/– mutants were retrogradely
traced following dual injections of DiA into S1 and DiI into V1
(Fig. 2C1), as an example of our more extensive analysis
(Wright et al. 2007). Results showed abnormal DiI labeling in
VB thalamic nuclei, indicating caudally shifted projections
from VB to V1. VB nuclei were colabeled with DiA,
demonstrating the presence of normally projecting VB axons
to S1. DiI labeling of the dorsal LGN indicated that LGN axons
projected normally to V1 (Fig. 2C1). The projection of motor
thalamic axons to M1 was unaffected by loss of CHL1 (Wright
et al. 2007). This illustrates that loss of CHL1 causes caudal
misprojection of contingents of VB axons to V1.
In CHL1
–/–/L1
–/y mice injections (n = 4) of DiA into M1
(Fig. 2D1) resulted in normal labeling of thalamic motor nuclei
(VA/VL) and not VB (VPM, VPL) or other nuclei in each case
(Fig. 2D2). Injections of double mutants with DiI (n = 5) into S1
(Fig. 2D3 and Supplementary Fig. 1) resulted in normal labeling
of VB nuclei (VPM, VPL) and not dorsal LGN or other nuclei in
each case (Fig. 2D4). Injections of DiI or DiA into V1 (n = 7)
resulted in abnormal retrograde labeling of VB nuclei (VPM,
VPL) (Fig. 2D5,D7) and motor nuclei (VA/VL) (Fig. 2D6,D8) in
every case, in addition to normal labeling of the dorsal LGN
(Fig. 2D5,D7). This suggested that the combined loss of CHL1
and L1 caused caudal misprojection of contingents of both
motor and somatosensory thalamic axons to V1. Since the
dorsal LGN is laterally positioned in the DT, the misprojection
of VA axons, in particular, would also be shifted laterally to
some extent.
Mistargeting of motor and somatosensory thalamic axons
from VA/VL and VPM/VPL nuclei to V1 in the double mutants
was fully penetrant (7 of 7 injections) and was not observed in
single mutants (13/13 and in [Wright et al. 2007]). Caudal
misprojections of motor thalamic axons were never seen in
CHL1
–/– single mutants (Wright et al. 2007). No rostrally
directed misprojections were observed for any mutant. The
location along both rostrocaudal and mediolateral DT axes of
labeled nuclei in mutants appeared to correspond in general to
the location of WT nuclei, despite the presence of misproject-
ing axons, although the spread of dye labeling in DT nuclei
varied depending on the size of DiI/DiA injections. Because of
this variation, any alterations in mediolateral axon projections,
which are another important aspect of topography (Price et al.
2006; Bonnin et al. 2007; Powell et al. 2008), could not be
accurately assessed. Serial coronal sections through the DT or
cortex were examined in each case to assess the DiI/DiA
injection sites and location of retrograde label throughout the
DT, as shown for DiI injection into S1 of double mutants
(Supplementary Fig. 1).
Chi-square analysis indicated that aberrant mapping of motor
thalamic axons in CHL1
–/–/L1
–/y double mutants to V1 and of
somatosensory axons to V1 was significantly different from WT
(v2 = 8.78; 0.01 < P < 0.001). Normal positioning of the V1/V2
boundary (Fig. 1E--G) in double mutants suggested that the
posterior shift of VB axons to the visual cortex in double
mutants was not likely to be due to altered cortical arealization
in this region. Chi-square analysis further indicated that
mistargeting of somatosensory thalamic axon contingents to
V1 in CHL1
–/–/L1
–/y double mutants was not significantly
different from that in CHL1
–/– mice (Wright et al. 2007) (v2 =
0.034; P > 0.5), and thus is probably due to loss of CHL1
alone. In summary, these results showed that combined loss of
L1 and CHL1 causes mistargeting specifically of motor thalamic
axons from VA/VL to V1, whereas loss of either L1 or CHL1
alone has no effect on this projection.
L1 and CHL1 Mediate EphrinA5-Induced Growth Cone
Collapse
The striking posterior shift of motor thalamic axons to the
visual cortex in CHL1/L1 double mutants may be due to
defective repellent thalamic axon guidance at the intermedi-
ate target, the VTe, where axons are initially sorted to areas of
the cortex along the rostrocaudal axis (Dufour et al. 2003).
A high caudal to low-rostral gradient of EphrinA5 in the VTe
repels subpopulations of rostral thalamic axons, which express
EphA receptors in a high-rostral countergradient, so that
axons are guided to the motor cortex (Dufour et al. 2003).
EphrinA5 in the VTe is a ligand for EphA3, EphA4, and EphA7,
which are among the principal EphAs in the embryonic DT
(Mackarehtschian et al. 1999; Dufour et al. 2003; Yun et al.
2003; Torii and Levitt 2005; Miller et al. 2006). To address
whether CHL1 and/or L1 were capable of mediating the
EphrinA5 repellent axon response, growth cone collapse
assays were performed using dissociated cortical neurons
from WT, CHL1
–/– or L1
–/y mutant embryos (E14.5). Primary
cultures of cortical neurons from WT, CHL1
–/–, or L1
–/y
embryos were grown for 3 days followed by treatment for
30 min with 30 nM EphrinA5-Fc or nonimmune IgG as control.
F-actin was labeled using rhodamine-labeled phalloidin, and
axons were scored for growth cone collapse. Collapsed
growth cones had a bullet-shaped morphology in contrast to
uncollapsed growth cones, which were well spread and
displayed numerous filopodia and lamellipodia.
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Figure 2. Retrograde tracing of thalamic axons from distinct cortical areas in WT, CHL1/, L1/y, and CHL1//L1/y double mutant mice (P7). (A) Scheme showing results of
retrograde tracing of thalamocortical axons with DiI or DiA from different neocortical areas to distinct DT nuclei in WT mice. (A1) Retrograde labeling of WT motor thalamic nuclei
(VA/VL) but not VB nuclei (VPM, VPL) is shown following injection of DiI into M1. (A2) Retrograde labeling of WT dorsal LGN and VB is shown following dual injection of DiI into V1
and DiA into S1. Orientation of all sections in Figure 2 are indicated (R, rostral; L, lateral). Injection sites and position of the sections are diagrammatically illustrated in each panel.
(B) Scheme showing results of retrograde tracing of thalamocortical axons with DiI or DiA from different neocortical areas to distinct DT nuclei in L1/y mice. (B1) Retrograde
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EphrinA5-Fc induced robust growth cone collapse in WT
cortical neurons, increasing the percent of collapsed growth
cones by 50% over that of control neurons treated with
nonimmune IgG (Fig. 3A,B). EphrinA5-Fc treatment of L1
–/y
cortical neurons resulted in a growth cone collapse response
that was 18% lower than in WT neurons, while EphrinA5-Fc
treatment of CHL1
–/– cortical neurons resulted in a collapse
response that was 31% lower than in WT neurons. Basal growth
cone collapse in the presence of nonimmune IgGwas equivalent
forWT, L1
–/y, and CHL1
–/– cortical neurons andwas not different
from the corresponding untreated cultures (not shown). In
thalamic explants fromWTE14.5 embryos, EphrinA5 taggedwith
AP (EphrinA5-AP) induced a pronounced growth cone collapse
response relative to the Fc-AP--treated control (Fig. 3C,D). The
collapse response was nearly equivalent for WT cortical and
thalamic neurons. EphrinA5-AP--induced growth cone collapse
in CHL1
–/– thalamic explants was strongly abrogated compared
with EphrinA5-AP--treated WT explants (Fig. 3C,D). Due to
limitations in breeding L1 single and double mutants, it was not
practical to assay the collapse response in thalamic explants for
these mutant lines. In dissociated cultures of embryonic mouse
cortical neurons, L1 and CHL1 were coexpressed in most of the
cells (L1, 55/58 cells; CHL1, 56/58 cells) and were colocalized
along neurites and growth cones (Fig. 3E). However, the
intensity of immunofluorescence staining of each protein varied,
and someneurites exhibit stronger staining for either L1 orCHL1
(Fig. 3E). Similarly, L1 and CHL1were expressed and colocalized
in neurites and growth cones in the vast majority of embryonic
thalamic neurons in dissociated cultures (Fig. 3E).
In summary, CHL1 and L1 colocalized in growth cones of
cortical and thalamic neurons and mediated EphrinA5-induced
growth cone collapse in vitro. As CHL1, L1, and EphrinA5
(Henkemeyer et al. 1996) are expressed along the thalamo-
cortical pathway at E14.5, they may regulate repellent guidance
of thalamic axons to EphrinA5 in vivo.
L1 and CHL1 Selectively Associate with EphA Receptors
The findings that motor thalamic axons are shifted to the
visual cortex in CHL1/L1 double mutants and that the
EphrinA5 repellent response is impaired in cultured neurons
lacking either L1 or CHL1 raises the hypothesis that L1-CAMs
might interact with Eph receptors to mediate axon guidance
of DT axons at the VTe. To test this hypothesis, potential
interactions of CHL1 and L1 with EphA3, EphA4, EphA7, as
well as EphB2, an EphrinA5 receptor expressed in E14.5 DT
(Henkemeyer et al. 1996) were examined by coimmunopre-
cipitation. cDNA3 plasmids encoding CHL1 or L1 were
cotransfected with EphA3, EphA4, EphA7, or EphB2 for
transient expression in HEK293T cells. After 2 days, cell
lysates were subjected to immunoprecipitation and immuno-
blotting. Each molecule was effectively expressed in the cells,
as shown by immunoblotting of cell lysates (Fig. 4). L1 (~220
kDa doublet) coimmunoprecipitated with EphA3, EphA4, and
EphA7 (Fig. 4A,C) but not with EphB2 (Fig. 4D), demonstrat-
ing an interaction of L1 with each of the principal EphrinA5
receptors expressed in the embryonic DT during thalamo-
cortical axon pathfinding. Conversely, CHL1 coimmunopre-
cipitated with EphA7 (Fig. 4C) but not with EphA3, EphA4, or
EphB2 (Fig. 4A,B, and D), thus demonstrating selectivity in the
interaction of L1-CAMs with Eph receptors. EphA kinase
activation may be required for recruitment of L1-CAMs, as
EphA receptors are autoactivated when overexpressed
(Pasquale 2005). L1 and CHL1 antibodies did not cross-react
with EphA3, EphA4, or EphA7, as shown by immunoblotting of
lysates from HEK293 cells transfected with each receptor or
L1-CAM (Fig. 4E). These results demonstrate a specific
interaction of L1 and CHL1 with individual EphA receptors.
Such interactions were not observed by coimmunoprecipita-
tion from embryonic DT lysates or whole brain, possibly due
to a transient interaction or a requirement for ephrinA-
induced activation of EphA signaling, as overexpression of
EphAs in HEK293T cells routinely leads to ligand-independent
autoactivation of EphA tyrosine kinase. Also the association
may occur primarily in growth cones traversing the VTe,
which constitute a very small amount of protein from
embryonic brain or DT. The small size of the DT and VTe
limit biochemical confirmation of the associations demon-
strated in transfected HEK293 cells. It should be noted that L1
was shown to be recruited to EphA4 in platelet preparations,
and this depended on activation of the kinase (Prevost et al.
2002).
Discussion
Here, we report a novel cooperative function for the L1-CAM
family members CHL1 and L1 as mediators of topographic
mapping of thalamic axons to the neocortex. Deletion of both
CHL1 and L1 in a newly generated CHL1
–/–/L1
–/y double mutant
mouse disrupted area-specific targeting of thalamocortical
axons in a manner distinct from that in either of the single
mutants. Combined deletion of CHL1 and L1 caused con-
tingents of axons from motor (VA/VL) and somatosensory (VB)
thalamic nuclei to incorrectly target V1. L1 and CHL1 were
coexpressed in the embryonic DT (E14.5) and colocalized on
many axons within the thalamocortical projection as well as in
neuronal cultures. A novel function for L1 and CHL1 was
identified in mediating growth cone collapse to EphrinA5,
a repellent cue important in thalamocortical axon guidance
(Dufour et al. 2003; Cang et al. 2005), and each L1-CAM was
found to associate with distinct but overlapping EphA receptor
subclasses. These results suggest that functional complexes of
L1-CAMs with EphAs and other repellent guidance receptors
guide subpopulations of thalamic axons to distinct neocortical
areas essential for thalamocortical connectivity.
labeling of VL but not VB nuclei (VPM, VPL) following injection of DiA into M1. (B2) Labeling of VB but not dorsal LGN following injection of DiI into S1. (B3) Retrograde labeling of
dorsal LGN following injection of DiI into V1. (C) Scheme showing results of retrograde tracing of thalamocortical axons from different neocortical areas to distinct DT nuclei of
CHL1/ mice, in which axon contingents from the VB nucleus misproject caudally to V1. (C1) Retrograde labeling of VB and dorsal LGN following dual injections of DiA into S1
and DiI into V1. Neuronal soma in VB nuclei are inappropriately labeled with DiI. Injection sites are shown below the scheme. (D) Scheme showing results of retrograde tracing of
thalamocortical axons from different neocortical areas to distinct DT nuclei of CHL1//L1/y mice, in which axon contingents from VA/VL and VB nuclei misprojected caudally to
V1. (D1) Injection site of DiA into M1 of the neocortex (m, medial; l, lateral). (D2) Retrograde labeling of VA and VL but not VB nuclei (VPM, VPL) following DiA injection into M1.
4#,6-diamidino-2-phenylindole staining shows hippocampus (HC) and habenula (Hb). (D3) Injection site of DiI into S1 (m, medial; l, lateral). (D4) Labeling of VPM and VPL nuclei
following DiI injection into S1. (D5) Labeling of dorsal LGN, VPM, and VPL nuclei following DiI injection into V1. (D6) Labeling of VA and VL nuclei following DiI injection into V1.
(D7) Labeling of VPM and dorsal LGN following DiA injection into V1. (D8) Labeling of VA and VL nuclei following DiA injection into V1. M1, primary motor cortex; S1, primary
somatosensory cortex; V1, primary visual cortex. Magnification bars equal 500 lm in all panels except D8 (300 lm).
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Figure 3. L1 and CHL1 mediate EphrinA5-induced growth cone collapse. (A) Dissociated cortical neurons from WT, L1/y, and CHL1/ embryos (E14.5) were cultured for 3
days, treated with 30 nM EphrinA5 or 30 nM IgG for 30 min, fixed, and stained with phalloidin for visualizing F-actin. Images are representative examples of noncollapsed and
collapsed growth cones scored following IgG or EphrinA5-Fc treatment. Magnification bar 5 5 lm. (B) Quantification of growth cone collapse in dissociated cortical neuron
cultures shown in A, in response to control IgG or EphrinA5-Fc. Percent growth cone collapse is expressed as the mean ± standard error of the mean (SEM) (n 5 number of
growth cones scored). Asterisk indicates significant differences (P\ 0.05; 2-tailed t-test). (C) WT and CHL1/ thalamic explants (E14.5) were cultured for 3 days, treated with
30 nM EphrinA5-AP or 30 nM Fc-AP, fixed, and stained with phalloidin. Representative examples of noncollapsed and collapsed growth cones following control Fc-AP or EphrinA5-
AP treatment. Magnification bar in A 5 5 lm. (D) Quantification of growth cone collapse from thalamic explants in C, in response to EphrinA5-AP. Percent growth cone collapse
is mean ± SEM. n 5 number of growth cones scored. Asterisk indicates significant differences in means (P\ 0.05; 2-tailed t-test). (E) Immunofluorescence staining showing
colocalization of L1 and CHL1 in embryonic mouse cortical and thalamic neurons in dissociated cultures. Colocalization was evident in growth cones of cortical and thalamic
neurons (lines). Some neurites of cortical neurons appeared enriched for L1 (arrows) and others for CHL1 (arrowheads). Control staining without primary antibodies is shown for
cortical neurons (C1) and thalamic neurons (C2). Magnification bars 5 20 lm.
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Axon tracing with DiI/DiA revealed a cooperative role for L1
and CHL1 in topographic mapping of contingents of thalamic
axons from motor thalamic nuclei to the neocortex. CHL1
–/–/
L1
–/y double mutants exhibited a caudal shift of axons from
VA/VL motor thalamic nuclei to V1, which was not observed in
L1
–/y or CHL1
–/– single mutants (the present study and [Wright
et al. 2007]). CHL1
–/–/L1
–/y double mutants additionally showed
a caudal shift of axon contingents from the VB complex to V1,
but this was probably due to loss of CHL1, which resulted in
the same misprojection as a consequence of impaired axon
Figure 4. L1 and CHL1 associate with EphA receptors. (A--D) CHL1 or L1 were
coexpressed with EphA3, EphA4, EphA7, or EphB2 from pcDNA3 plasmids after
transient transfection of HEK293T cells. Lysates (500-lg protein) were immunopre-
cipitated (IP) using antibodies against EphA3, EphA4, EphA7, L1, CHL1, or normal IgG
and immunoblotted (IB) for the indicated protein. Blots were reprobed with antibodies
used for IP. IB of cell lysates (25 lg) confirmed expression of each protein in
transfected cells. Position of molecular weight markers are indicated by solid
arrowheads (250 kDa) and open arrowheads (130 kDa). L1 protein was detected in
(A) EphA3, (B) EphA4, and (C) EphA7 immunoprecipitates. CHL1 was not detected in
the immunoprecipitates of (A) EphA3 or (B) EphA4 but was detected in (C) EphA7
immunoprecipitates. EphB2 was not detected in either (D) L1 or CHL1
immunoprecipitates. (E) EphA3, EphA4, EphA7, L1, or CHL1 were expressed alone
from pcDNA3 plasmids by transient transfection of HEK293T cells. Lysates (25-lg
protein) were immunoblotted with antibodies L1 or CHL1 to demonstrate their
specificity and showed no cross-reactivity with EphA receptors (upper panels). In
lower panels, blots were stripped and reprobed with EphA-specific antibodies to
confirm expression of each protein in transfected cells.
Figure 5. Schematic diagrams of thalamocortical trajectories based on axon tracing
experiments in different mouse genotypes: (A) WT, (B) CHL1/, (C) CHL1/ L1/y,
(D) L1/y, (E) EphrinA5//EphA4/, and (F) Neuropilin-1 mutant defective in
Sema3A binding. Normal projections are depicted as solid lines and misprojections as
dashed lines. In CHL1//L1/y and EphrinA5//EphA4/ mutants, VA or VL axon
contingents caudally misproject to V1 and VB, respectively. Note similar misprojection
of VB axon contingents to V1 in CHL1/ and Neuropilin1Sema3A/ mutants. L1/y
mutants show normal projections. The location of rostrocaudal gradients of ephrinA5,
Sema3A, and EphA3, 4, 7 are indicated by shading.
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repulsion from the high-caudal Sema3A gradient in the VTe
(Wright et al. 2007). Retrograde thalamocortical axon tracing
in L1
–/y mice at P5 showed that loss of L1 alone had no
significant impact on thalamocortical mapping to these neo-
cortical areas, in accord with axon tracing by other methods at
P14 (Wiencken-Barger et al. 2004).
The finding that motor thalamic axons from VA/VL were
caudally shifted in CHL1
–/–/L1
–/y double mutant mice, suggests
that these L1-CAMs may interact with the EphrinA/EphA
system for repellent axon guidance of motor thalamic axons
at the VTe. Such a role is in accord with colocalization of CHL1
and L1 on many thalamic axons within the VTe during
thalamocortical axon sorting, their association with EphA
receptors, and their requirement for EphrinA5-induced growth
cone collapse. A high caudal to low-rostral gradient of EphrinA5
in the VTe directs rostral thalamic axons toward the rostral
neocortex, through interactions with countergradients of
EphA3, EphA4, and EphA7 on thalamocortical axons
(Mackarehtschian et al. 1999; Dufour et al. 2003). As shown
schematically (Fig. 5), CHL1
–/–/L1
–/y double mutants exhibited
a more severe caudal mistargeting phenotype in which
contingents of VA/VL axons caudally misprojected to V1,
compared with mutants lacking both EphrinA5 and EphA4 (or
mutants lacking EphA7) (Dufour et al. 2003), in which motor
thalamic axons are caudally shifted only to S1 (Dufour et al.
2003). Cooperative signaling involving both CHL1/EphA7 and
L1/EphA3,-A4,-A7 acting as coreceptors for EphrinA5 would be
expected to exert a stronger effect than single coreceptors in
repelling motor thalamic axons from the posterior high
EphrinA5 gradient in the VTe. Retrograde tracing did not allow
us to assess subtle mediolateral shifts of mutant DT axons,
which could also be affected by ephrinA/EphA signaling or to
determine where in the thalamocortical trajectory misguidance
occurred.
Our results do not implicate a cooperative role for L1 and
CHL1 in transducing signals for Sema3A-induced axon re-
pulsion, although L1, like CHL1, binds Neuropilin-1 and serves
as a coreceptor for Sema3A in growth cone collapse (Bechara
et al. 2008). Sema3A acts as a caudal repellent for VB axons in
the VTe mediated by CHL1 interaction with Neuropilin-1
(Wright et al. 2007). Like CHL1 null mutants, mice expressing
Neuropilin-1 mutated in the Sema3A binding site (Wright et al.
2007) show caudal shifts of VB axon contingents to V1 (Fig. 5).
Loss of CHL1 alone (Wright et al. 2007) but not L1 alone
(shown here and [Wiencken-Barger et al. 2004]) caused VB
axons to caudally misproject to V1; thus, the caudal mistarget-
ing of VB axons to V1 observed in the double mutant is likely
due to loss of CHL1 alone.
L1 and CHL1 may also contribute to EphrinA/EphA-
mediated inter-areal and intra-areal targeting of thalamocort-
ical axons in the neocortex as well as the corticothalamic
projection. EphrinA5 gradients are expressed in complex
patterns in the developing neocortex (Mackarehtschian et al.
1999; Yun et al. 2003), where they may act as cortical cues for
guidance of thalamic axons to correct cortical areas. EphrinAs
have also been shown to regulate intra-areal thalamocortical
axon targeting within V1 (Cang et al. 2005; Pfeiffenberger
et al. 2005). Furthermore, EphA7 is required for reciprocal
corticothalamic axon targeting within thalamic nuclei (Torii
and Levitt 2005). CHL1 and L1 might contribute to the
corticothalamic projection, as CHL1 binds EphA7, and loss of
L1 causes hyperfasciculation and reduced numbers of cortico-
thalamic axons, with fewer axons reaching the DT (Ohyama
et al. 2004). If corticothalamic axons reciprocally influence
thalamocortical targeting, as postulated in the ‘‘handshake’’
hypothesis (Molnar et al. 1998), reduced numbers of cortico-
thalamic axons reaching the DT in L1-CAM mutant mice,
might cause DT axon subpopulations to misproject. Due to
limited availability and inefficient breeding of CHL1
–/–/L1
–/y
double mutant mice, it was not feasible to analyze thalamic
axon guidance at embryonic stages to assess their function
either at the VTe or dorsal telencephalon. Furthermore, we
do not know if the observed mapping phenotype of double
mutants at P7 is stable or transient, as these mice are difficult
to maintain at older ages.
Both L1 and CHL1 mediated growth cone collapse to
EphrinA5 in cortical and thalamic neurons, however, they
displayed specificity in their interactions with EphA subclasses.
L1 associated with EphA3, -A4, and -A7, whereas CHL1
preferentially associated with EphA7. L1-CAMs do not seem
to control repellent responses to all cue, as L1 mediates growth
cone collapse to Sema3A but not Sema3B or Sema3E (Castellani
et al. 2000). In the mouse thalamocortical pathway, distinctive
patterns of expression have been demonstrated for EphrinAs
(EphrinA3, -A4, and -A5 [Mackarehtschian et al. 1999]) and
EphA receptors (EphA3, -A4, and -A7 [Mackarehtschian et al.
1999; Torii and Levitt 2005; Uziel et al. 2006]). Interestingly,
EphA4 and EphA7 have been shown to selectively bind
different EphrinAs (Janis et al. 1999). Since L1-CAMs mediate
EphrinA-induced growth cone collapse, the interaction of
L1 and CHL1 with distinct EphA receptor classes might confer
differential responsiveness of growth cones within neuronal
subpopulations to different EphrinA gradients in the
developing brain, enabling more precise thalamocortical axon
targeting.
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